Trinity Biotech Plc (TRIB)
7.00
+1.23
(+21.32%)
USD |
NASDAQ |
Oct 06, 16:00
6.00
-1.00
(-14.29%)
After-Hours: 20:00
Trinity Biotech Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.552M |
| September 30, 2025 | -0.0714M |
| June 30, 2025 | -1.671M |
| March 31, 2025 | -2.962M |
| December 31, 2024 | 3.277M |
| September 30, 2024 | -5.819M |
| June 30, 2024 | -3.08M |
| March 31, 2024 | -4.823M |
| December 31, 2023 | -0.966M |
| September 30, 2023 | -6.523M |
| June 30, 2023 | -6.326M |
| March 31, 2023 | -5.364M |
| December 31, 2022 | 0.6213M |
| September 30, 2022 | -1.024M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 1.484M |
| September 30, 2021 | -0.386M |
| June 30, 2021 | 1.213M |
| March 31, 2021 | 6.083M |
| December 31, 2020 | 8.478M |
| September 30, 2020 | 7.031M |
| June 30, 2020 | 2.748M |
| March 31, 2020 | 1.502M |
| December 31, 2019 | -7.633M |
| Date | Value |
|---|---|
| September 30, 2019 | 4.633M |
| June 30, 2019 | 1.393M |
| March 31, 2019 | 3.028M |
| December 31, 2018 | -0.069M |
| September 30, 2018 | 2.603M |
| June 30, 2018 | -0.591M |
| March 31, 2018 | 0.783M |
| December 31, 2017 | -0.791M |
| September 30, 2017 | 4.071M |
| June 30, 2017 | 1.134M |
| March 31, 2017 | 0.236M |
| December 31, 2016 | -3.594M |
| September 30, 2016 | 7.686M |
| June 30, 2016 | -0.102M |
| March 31, 2016 | 1.634M |
| December 31, 2015 | 5.727M |
| September 30, 2015 | 3.595M |
| June 30, 2015 | -0.0253M |
| March 31, 2015 | 1.654M |
| December 31, 2014 | 8.734M |
| September 30, 2014 | 5.164M |
| June 30, 2014 | 1.176M |
| March 31, 2014 | 0.8013M |
| December 31, 2013 | 0.3951M |
| September 30, 2013 | 3.431M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| DBV Technologies SA | -52.52M |
| Cellectis SA | -14.34M |
| Akari Therapeutics Plc | -3.112M |
| Autolus Therapeutics Plc | -25.16M |
| Evaxion AS | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -12.50M |
| Free Cash Flow Per Share (Quarterly) | -3.790 |
| Free Cash Flow to Equity (Quarterly) | -23.13M |
| Free Cash Flow to Firm (Quarterly) | 10.18M |
| Free Cash Flow Yield | -288.7% |